Published in Curr Probl Dermatol on November 07, 2017
Psoriasis and pustular dermatitis triggered by TNF-{alpha} inhibitors in patients with rheumatologic conditions. Arch Dermatol (2007) 4.36
Prediction of spontaneous autoimmune diabetes in NOD mice by quantification of autoreactive T cells in peripheral blood. J Clin Invest (2003) 2.37
Topical resiquimod promotes priming of CTL to parenteral antigens. Vaccine (2009) 1.50
Usefulness of Interferon-γ release assays in the diagnosis of erythema induratum. Arch Dermatol (2011) 1.40
In situ beta cell death promotes priming of diabetogenic CD8 T lymphocytes. J Immunol (2002) 1.30
Expansion of antigen-specific regulatory T cells with the topical vitamin d analog calcipotriol. J Immunol (2009) 1.26
New concepts in antimalarial use and mode of action in dermatology. Dermatol Ther (2007) 1.24
Phagocytosis of apoptotic cells by macrophages from NOD mice is reduced. Diabetes (2002) 1.20
Optimization of epicutaneous immunization for the induction of CTL. Vaccine (2003) 1.19
Decidual NK cells alter in vitro first trimester extravillous cytotrophoblast migration: a role for IFN-gamma. J Immunol (2006) 1.17
Better influenza vaccines for older people: what will it take? J Infect Dis (2008) 1.17
Pathophysiology of cutaneous lupus erythematosus. Clin Rev Allergy Immunol (2007) 1.11
TLR9 blockade inhibits activation of diabetogenic CD8+ T cells and delays autoimmune diabetes. J Immunol (2010) 1.09
Molecular markers of early-stage mycosis fungoides. J Invest Dermatol (2012) 1.04
Tolerance induction by transcutaneous immunization through ultraviolet-irradiated skin is transferable through CD4+CD25+ T regulatory cells and is dependent on host-derived IL-10. J Immunol (2006) 1.00
Differences in body mass index among individuals with PsA, psoriasis, RA and the general population. Rheumatology (Oxford) (2011) 1.00
Active vitamin D (1,25-dihydroxyvitamin D3) increases host susceptibility to Citrobacter rodentium by suppressing mucosal Th17 responses. Am J Physiol Gastrointest Liver Physiol (2012) 0.95
Livedoid vasculopathy: an in-depth analysis using a modified Delphi approach. J Am Acad Dermatol (2013) 0.94
Topical CpG enhances the response of murine malignant melanoma to dacarbazine. J Invest Dermatol (2008) 0.93
Reversible retiform purpura: a sign of cocaine use. CMAJ (2011) 0.92
Thymocyte selection-associated high mobility group box gene (TOX) is aberrantly over-expressed in mycosis fungoides and correlates with poor prognosis. Oncotarget (2014) 0.92
Synthetic methylated CpG ODNs are potent in vivo adjuvants when delivered in liposomal nanoparticles. Int Immunol (2009) 0.90
Epicutaneous application of CpG oligodeoxynucleotides with peptide or protein antigen promotes the generation of CTL. J Invest Dermatol (2004) 0.89
Treatment of atypical nevi with imiquimod 5% cream. Arch Dermatol (2007) 0.85
Islet allograft rejection is independent of toll-like receptor signaling in mice. Transplantation (2009) 0.85
Psychiatric disorders in patients with immune-mediated inflammatory diseases: prevalence, association with disease activity, and overall patient well-being. J Rheumatol Suppl (2011) 0.85
IFN-gamma-mediated extravillous trophoblast outgrowth inhibition in first trimester explant culture: a role for insulin-like growth factors. Mol Hum Reprod (2008) 0.83
Type 1 IFN-induced protein MxA and plasmacytoid dendritic cells in lesions of morphea. Exp Dermatol (2012) 0.83
Murine models of cutaneous involvement in lupus erythematosus. Autoimmun Rev (2009) 0.82
Topical TLR9 agonists induce more efficient cross-presentation of injected protein antigen than parenteral TLR9 agonists do. Eur J Immunol (2007) 0.82
Progression of spontaneous autoimmune diabetes is associated with a switch in the killing mechanism used by autoreactive CTL. Int Immunol (2004) 0.80
Inhibition of cathepsin S reduces allogeneic T cell priming but not graft-versus-host disease against minor histocompatibility antigens. Biol Blood Marrow Transplant (2011) 0.78
Antennapedia transduction sequence promotes anti tumour immunity to epicutaneously administered CTL epitopes. Vaccine (2004) 0.78
Skin immune responses to peptide and protein antigen are TLR4 independent. Cell Immunol (2003) 0.78
Tumor necrosis factor-a inhibition and palmoplantar pustulosis: Janus-faced therapy? J Rheumatol (2007) 0.77
Topical CpG adjuvantation of a protein-based vaccine induces protective immunity to Listeria monocytogenes. Clin Vaccine Immunol (2014) 0.77
Atrophie blanche: is it associated with venous disease or livedoid vasculopathy? Adv Skin Wound Care (2014) 0.77
Decidual NK cell-derived conditioned medium (dNK-CM) mediates VEGF-C secretion in extravillous cytotrophoblasts. Am J Reprod Immunol (2011) 0.77
Quality of life in patients with immune-mediated inflammatory diseases. J Rheumatol Suppl (2011) 0.77
Clinical and genetic registries in psoriatic disease. J Rheumatol (2008) 0.76
Making necrotizing vasculitis simple. J Cutan Med Surg (2013) 0.75
Combination Therapy With Tofacitinib and IL-12/23, IL-23, or IL-17A Inhibition for the Treatment of Refractory Psoriatic Arthritis: A Case Series. J Clin Rheumatol (2022) 0.75